Search

The European Union has signed up Croatia, Macedonia and Serbia to associated status, enabling them to participate fully in the EU’s Seventh Research Framework Programme.

India’s biotech sector is powering ahead, with 30 per cent annual growth over the past four years. But venture capitalists are still not tempted to invest.

Can European R&D play its way to the top of the international league? In an unprecedented gathering Science|Business brought together some of the leading protagonists to discuss possible tactics.

In an unprecedented move, ETH Zürich has filed a formal complaint over the distribution of the ETH domain’s budget for 2008.

An R&D conference highlights the mutual incomprehension dividing industry and academics in Europe – and some suggestions for bridging the gap.